Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080628305> ?p ?o ?g. }
- W3080628305 endingPage "2736" @default.
- W3080628305 startingPage "2714" @default.
- W3080628305 abstract "Abstract Background Immunomodulatory strategies in heparin‐induced thrombocytopenia (HIT) include the use of intravenous immune globulin (IVIG) and therapeutic plasma exchange (TPE). The optimal application of these therapies is unknown and outcomes data are limited. We investigated treatment categories and laboratory and clinical outcomes of IVIG and/or TPE in HIT with a systematic literature review. Study Design and Methods We searched MEDLINE, Embase, and Web of Science through December 2019 for studies combining controlled vocabulary and keywords related to thrombocytopenia, heparin, TPE, and IVIG. The primary outcome was treatment indication. Secondary outcomes were platelet recovery, HIT laboratory parameters, heparin re‐exposure, and post‐treatment course. Case‐level data were analyzed by qualitative synthesis. Results After 4241 references were screened, we identified 60 studies with four main categories of IVIG and/or TPE use as follows: (a) treatment of refractory HIT (n = 35; 31%); (b) initial therapy (n = 45; 40%); (c) cardiopulmonary bypass surgery (CPB; n = 30; 27%); and (d) other (n = 2; 2%). IVIG was most commonly used for the treatment of refractory HIT while TPE was primarily used to facilitate heparin exposure during CPB. Both IVIG and TPE were equally used as initial therapy. Heparin re‐exposure occurred without thrombotic event in 29 TPE‐treated patients and three IVIG‐treated patients. Conclusion In patients with HIT, both TPE and IVIG are used for initial therapy or treatment of refractory HIT. However, TPE is more commonly used in patients undergoing CPB. Prospective studies may help clarify which treatment is indicated in HIT population subsets." @default.
- W3080628305 created "2020-09-01" @default.
- W3080628305 creator A5000273872 @default.
- W3080628305 creator A5001257182 @default.
- W3080628305 creator A5001477473 @default.
- W3080628305 creator A5006839060 @default.
- W3080628305 creator A5023920381 @default.
- W3080628305 creator A5035882910 @default.
- W3080628305 creator A5043441297 @default.
- W3080628305 creator A5047472906 @default.
- W3080628305 creator A5059991352 @default.
- W3080628305 creator A5066837873 @default.
- W3080628305 creator A5082959423 @default.
- W3080628305 date "2020-08-19" @default.
- W3080628305 modified "2023-10-12" @default.
- W3080628305 title "Therapeutic plasma exchange and intravenous immune globulin in the treatment of <scp>heparin‐induced</scp> thrombocytopenia: A systematic review" @default.
- W3080628305 cites W14403618 @default.
- W3080628305 cites W1641772231 @default.
- W3080628305 cites W1685331907 @default.
- W3080628305 cites W1966427919 @default.
- W3080628305 cites W1973068705 @default.
- W3080628305 cites W1974252173 @default.
- W3080628305 cites W1975437100 @default.
- W3080628305 cites W1976015722 @default.
- W3080628305 cites W1979026204 @default.
- W3080628305 cites W1982536750 @default.
- W3080628305 cites W1987284548 @default.
- W3080628305 cites W2005501262 @default.
- W3080628305 cites W2009406286 @default.
- W3080628305 cites W2016730510 @default.
- W3080628305 cites W2022027523 @default.
- W3080628305 cites W2036468968 @default.
- W3080628305 cites W2063480742 @default.
- W3080628305 cites W2075546761 @default.
- W3080628305 cites W2085236496 @default.
- W3080628305 cites W2085296783 @default.
- W3080628305 cites W2089926054 @default.
- W3080628305 cites W2103182354 @default.
- W3080628305 cites W2126642646 @default.
- W3080628305 cites W2133493476 @default.
- W3080628305 cites W2140436541 @default.
- W3080628305 cites W2141905056 @default.
- W3080628305 cites W2150922204 @default.
- W3080628305 cites W2157919846 @default.
- W3080628305 cites W2165553527 @default.
- W3080628305 cites W25152566 @default.
- W3080628305 cites W2559922767 @default.
- W3080628305 cites W2604966034 @default.
- W3080628305 cites W2605638326 @default.
- W3080628305 cites W2642152082 @default.
- W3080628305 cites W2749355395 @default.
- W3080628305 cites W2753807115 @default.
- W3080628305 cites W2762725046 @default.
- W3080628305 cites W2762743046 @default.
- W3080628305 cites W2766893436 @default.
- W3080628305 cites W2780546185 @default.
- W3080628305 cites W2788728681 @default.
- W3080628305 cites W2791871259 @default.
- W3080628305 cites W2800434387 @default.
- W3080628305 cites W2801068775 @default.
- W3080628305 cites W2802538683 @default.
- W3080628305 cites W2810644038 @default.
- W3080628305 cites W2810748481 @default.
- W3080628305 cites W28861116 @default.
- W3080628305 cites W2900328764 @default.
- W3080628305 cites W2902914300 @default.
- W3080628305 cites W2905284839 @default.
- W3080628305 cites W2916482856 @default.
- W3080628305 cites W2922152496 @default.
- W3080628305 cites W2933276402 @default.
- W3080628305 cites W2938615119 @default.
- W3080628305 cites W2954146049 @default.
- W3080628305 cites W2955990262 @default.
- W3080628305 cites W2959585711 @default.
- W3080628305 cites W2963319687 @default.
- W3080628305 cites W2964021825 @default.
- W3080628305 cites W2967026425 @default.
- W3080628305 cites W2979069837 @default.
- W3080628305 cites W2986140651 @default.
- W3080628305 cites W2986986924 @default.
- W3080628305 cites W3024504112 @default.
- W3080628305 cites W3028128266 @default.
- W3080628305 cites W1990297938 @default.
- W3080628305 cites W2338999555 @default.
- W3080628305 doi "https://doi.org/10.1111/trf.16018" @default.
- W3080628305 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32812222" @default.
- W3080628305 hasPublicationYear "2020" @default.
- W3080628305 type Work @default.
- W3080628305 sameAs 3080628305 @default.
- W3080628305 citedByCount "19" @default.
- W3080628305 countsByYear W30806283052020 @default.
- W3080628305 countsByYear W30806283052021 @default.
- W3080628305 countsByYear W30806283052022 @default.
- W3080628305 countsByYear W30806283052023 @default.
- W3080628305 crossrefType "journal-article" @default.
- W3080628305 hasAuthorship W3080628305A5000273872 @default.
- W3080628305 hasAuthorship W3080628305A5001257182 @default.
- W3080628305 hasAuthorship W3080628305A5001477473 @default.